Wuthering Waves 3.0 livestream is available on both YouTube and Twitch.

Anthropic is launching Claude Code in Slack, allowing developers to delegate coding tasks directly from chat threads. The beta feature, available Monday as a research preview, builds on Anthropic’s ...

Lynk & Co’s 03+ TCR sold out almost immediately after launch, showing how serious interest in Chinese-built touring cars has become. The Lynk & Co 03+ TCR sold out immediately after its China launch.

Hyundai took its limited-production Elantra N TCR Edition to Los Angeles and announced that, against all odds, it will, indeed, be sold in the U.S. The model rocks unique features inspired by motor ...

Back in July, Hyundai's Canadian arm surprised the world with its own variant of the venerable Elantra N. That car, called the Elantra N TCR Edition, was inspired by an IMSA championship streak won ...

Players can head to one of these links to watch the Zenless Zone Zero 2.4 special program, On the Precipice of the Abyss.

TScan Therapeutics is laying off 30% of its workforce as the T-cell receptor (TCR) therapy biotech abandons a phase 1 solid tumor trial and focuses on patients with blood cancers. The company had ...

The final season of Stranger Things kicks off on November 26, and unsurprisingly, the series is getting some cool new merch to celebrate its ending. If you're a Stranger Things fan--or you're looking ...

At TopSpeed, William Clavey is Editor-at-Large, where he focuses on authority and exclusive content, reviews, news articles, features, and opinion pieces all while sharing his passion for everything ...

Kendall Myers is a Senior Author with Collider. As part of the TV and Movies Features team, she writes about some of the most popular releases before, during, and after they premiere. In three years, ...

The more track-focused version of the Hyundai Elantra N called the Elantra N TCR Edition is inching its way closer to the United States, as Hyundai Canada has just announced the extra-spicy ...

AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell therapy clearout. When AstraZeneca scooped up the company back in 2022, ...